Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OW5Y
|
||||
Former ID |
DIB004439
|
||||
Drug Name |
NW-1772
|
||||
Synonyms |
Monoamine oxidase B inhibitors (neurodegenerative disease), Newron; MAO-B inhibitors (neurodegenerative disease), Newron
|
||||
Indication | Neurodegenerative disease [ICD9: 330-337; ICD10:G30-G32] | Investigative | [543639] | ||
Company |
Newron Pharmaceuticals SpA
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
S(=O)(=O)(O)C.c12oc(=O)cc(c1ccc(c2)OCc1cc(Cl)ccc1)CNC
|
||||
Target and Pathway | |||||
Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [543639] | |
KEGG Pathway | Glycine, serine and threonine metabolism | ||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Tryptophan metabolism | |||||
Drug metabolism - cytochrome P450 | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Dopaminergic synapse | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.